Janux Therapeutics logo

Janux Therapeutics Employee Directory

Biotechnology ResearchCalifornia, United States51-200 Employees

Janux Therapeutics is a clinical-stage biotechnology company based in San Diego, California, focused on cancer immunotherapies. Its programs aim to induce tumor-specific immune responses that attack cancer cells while preserving healthy tissue. The company employs a platform masking approach to design candidates intended to overcome toxicity and efficacy limitations of traditional T cell engagers. The firm earned a Great Place to Work Certification in 2024.
In 2026, Janux announced a collaboration with Bristol Myers Squibb to develop a novel tumor-activated therapeutic for solid tumors, accompanied by an exclusive worldwide license agreement. It also unveiled a 'double-masked' T cell engager, representing a recent milestone in its development program.

Find Janux Therapeutics employees' phone numbers or email addresses

Janux Therapeutics Global Highlights

Location
Employees

North America
124

Minus sign iconPlus sign icon
  • United States Of America
    124

Europe
2

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    1
  • Ireland
    1

Janux Therapeutics's Leadership

  • Chief Financial Officer at Janux Therapeutics
    T. R.
    Chief Financial Officer
  • Senior Director, Clinical Operations at Janux Therapeutics
    A. R.
    Senior Director, Clinical Operations
  • Program Manager at Janux Therapeutics
    A. D.
    Program Manager
  • Scientist, Immunology (oncology) at Janux Therapeutics
    M. N.
    Scientist, Immunology (oncology)
  • Employee at Janux Therapeutics
    D. C.
  • Employee at Janux Therapeutics
    S. W.

Janux Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Operations
  • Quality Assurance
  • Accounting
  • Finance
  • Other
  • Information Technology
  • Biotechnology
  • Business
  • Entrepreneurship
  • Administrative

Contact profiles from Janux Therapeutics

Name
Title
Contact
Location
Last Update
  • Chief Financial Officer at Janux Therapeutics
    T. R.
    Chief Financial Officer
    Jun 27, 2025
  • Senior Director, Clinical Operations at Janux Therapeutics
    A. R.
    Senior Director, Clinical Operations
    Bay
    May 04, 2026
  • Program Manager at Janux Therapeutics
    A. D.
    Program Manager
    Aug 18, 2026
  • Scientist, Immunology (oncology) at Janux Therapeutics
    M. N.
    Scientist, Immunology (oncology)
    May 04, 2026
  • Employee at Janux Therapeutics
    D. C.
    Ireland
    Jul 01, 2026
  • Employee at Janux Therapeutics
    S. W.
    United Kingdom, Greater London
    Apr 07, 2023

Frequently Asked Questions

What is Janux Therapeutics known for?

Minus sign iconPlus sign icon
Janux Therapeutics was founded in 2017 and operates in the Biotechnology Research industry. Explore Janux Therapeutics's company overview page for more information.

What is Janux Therapeutics's most common email format?

Minus sign iconPlus sign icon
Janux Therapeutics employees' email format typically follows the pattern of FLast@januxrx.com. Trying to find reliable and up-to-date employee contact data? Find more Janux Therapeutics email formats with LeadIQ.

How many employees does Janux Therapeutics have currently?

Minus sign iconPlus sign icon
Janux Therapeutics has approximately 120 employees as of August 2026. These team members are located across 2 continents, including North America and Europe.

Who are Janux Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Janux Therapeutics's key employees include:

  • Chief Financial Officer: T. R.
  • Senior Director, Clinical Operations: A. R.
  • Program Manager: A. D.
  • Scientist, Immunology (oncology): M. N.
  • : D. C.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Β© LeadIQ, Inc. All rights reserved.